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Abstract
Background: This study aimed to investigate the prevalence of healthcare-associated infection (HAI) in the
China-Japan Friendship Hospital, a tertiary level hospital in Beijing, China.
Methods: We defined HAI using the criteria established by the Ministry of Health of the People’s Republic of China.
Three cross-sectional surveys were conducted from 2012 to 2014. Inpatients who had been hospitalized for at least
48 h were surveyed. Information on HAI prevalence, isolated pathogens and use of antibiotics were collected.
Logistic regression models were used to assess the associations between HAI and potential risk factors.
Results: During three cross-sectional surveys, a total number of 4,029 patients were included (1,233 patients in
2012, 1,220 patients in 2013 and 1,576 patients in 2014). The overall prevalence of patients with HAI was 3.6 %
(95 % confidence interval (CI) 3.1 %–4.2 %). Respiratory tract infections were the most common type (64.7 %) of
HAIs, followed by urinary tract infections (12.6 %) and bloodstream infections (5.4 %). HAI occurrences were
significantly associated with male sex (odds ratio (OR) = 2.25, 95 % CI 1.53-3.32), age over 85 years (OR = 4.74, 95 %
CI 2.54–8.83), hospitalization in the intensive care units (ICUs) (OR = 2.42, 95 % CI 1.31–4.49), indwelling urinary
catheter (OR = 4.21, 95 % CI 2.46–7.20) and mechanical ventilation (OR = 2.31, 95 % CI 1.30–4.09). Gram-negative
bacteria were found to be the most isolated pathogens (67.1 %), with gram-positive bacteria and fungi accounted
for 20.3 % and 10.5 %, respectively. Antibiotics were administered to 34.3 % of the included patients over the study
period.
Conclusions: The overall HAI prevalence in our hospital is similar to previous studies that were conducted in other
areas of China, and the respiratory tract infection should be the priority in HAI reduction control within China. We
should focus HAI reduction efforts on patients with advanced age, hospitalization in the ICU and indwelling
devices.
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Background
Healthcare-associated infection (HAI) continues to be a
major public health concern worldwide [1]. As a common
cause of morbidity and mortality among hospitalized pa-
tients, HAI is associated with prolonged hospital stay and
increased healthcare cost [2, 3]. Surveillance has been rec-
ognized as an important method to reduce HAI. A well-
conducted prospective longitudinal surveillance combined
with infection control program is an ideal approach to re-
duce the incidence of HAI and to reduce its associated
costs accordingly [4–6]. However, it is expensive and time
consuming to conduct prospective surveillance. In contrast,
cross-sectional survey is relatively more cost-effective to
obtain basic HAI information, such as prevalence, isolated
pathogens and antibiotic uses [7]. In addition, in countries
with limited resources, especially for hospitals that are not
yet able to carry out surveillance on the incidence of HAI,
cross-sectional studies are preferred to determine the mag-
nitude of HAI and are necessary to initiate effective preven-
tion and control program. Furthermore, repeated cross-
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sectional surveys could provide meaningful data to investi-
gate potential trends of HAI [8, 9].
Currently, several cross-sectional surveys have been con-
ducted in Anhui and Hubei Province in China [10–12].
However, there have been no published records so far on
HAI in Beijing, the capital of China, which has a relatively
large number of hospitals and patients [13]. In order to bet-
ter understand HAI epidemiology and to improve further
infection control program, we conducted three annual
cross-sectional surveys on HAI in the China-Japan




The protocol of our study was approved by the Ethical
Review Committee of China-Japan Friendship Hospital.
This observational study did not affect the clinical
course of treatment, and all the data was analyzed an-
onymously. Thus, neither verbal nor written informed
consent was obtained from participants. We were also
exempt from requiring ethical approval due to delinking
of personal identifiers from clinical and laboratory data.
Study design
China-Japan Friendship Hospital, a tertiary hospital
founded in 1984 in Beijing, China, is comprised of 43 clin-
ical departments (13 medical departments, 12 surgical de-
partments, 10 traditional Chinese medical departments,
five Intensive care units, one pediatric department, one
Gynecology/obstetrics department and one Ophthalmol-
ogy/otorhinolaryngology department), with 1,377 hospital
beds in 2012, 1,405 in 2013 and 1,747 in 2014. The hospital
admitted 44,825 inpatients in 2012, 50,263 in 2013 and
59,308 in 2014. It also serves 2.3 million outpatients every
year. Three single day cross-sectional surveys were con-
ducted by the Infection Management and Disease Preven-
tion Department on May 16th 2012, Sep 2nd 2013 and May
21st 2014. With the same methodology, these three cross-
sectional surveys adopted an identical questionnaire de-
signed by Beijing Quality Control Center for the Manage-
ment of Hospital Infection. Patients who had been
admitted to the hospital for at least 48 h at 8 a.m. on the
survey days were included.
Case definition
HAI was defined according to the criteria established by
the Ministry of Health (MOH) of the People’s Republic
of China [14], and was a modification of the definition
from the USA Centers for Disease Control and Preven-
tion (CDC) [15]. According to the CDC’s definition, re-
spiratory tract infection (RTI) contains cases of
“pneumonia” and “lower respiratory tract infection other
than pneumonia” only, whereas the MOH’s version also
includes “Upper respiratory infection” if a patient has a
fever with higher than 38 °C. Moreover, while patients
below 12 months of age are considered as a separate
group in the CDC’s definition, they are included in the
overall sustainable population for HAI in the MOH’s
definition, except for cardiovascular and central nervous
system infections.
In our study, infection occurred after hospital admis-
sion (≥48 h) that was neither present nor incubating on
admission was considered as HAI. The main outcomes
were common HAIs, including RTI, urinary tract infec-
tion (UTI), bloodstream infection (BSI), surgical site in-
fection (SSI), digestive tract infection (DTI), skin and
soft tissue infection (SSTI) and “Others” (which could
not be classified into any of above infections). Where
the same patient had more than one type of infection,
they were counted in each separate category.
Isolated microorganisms implicated in infections were
categorized as colonizers or pathogens according to
medical records and patients’ symptoms. Patients who
were receiving antibiotics on the survey day were identi-
fied. In addition, antimicrobial treatment was recorded if
the antimicrobial agent was still prescribed on the treat-
ment chart at the time of survey. In the case of surgical
prophylaxis, any single dose of an antimicrobial agent
given within the 24-h period before 8:00 a.m. on the sur-
vey day was recorded. Antiviral drugs and tuberculo-
statics were beyond the scope of our research.
Data collection
A team working in the Infection Management and Dis-
ease Prevention Department that consisted of a clinical
microbiologist, an epidemiologist, two physicians, and
two public health physicians, had overall accountability
for the study. The team was responsible for the training
and supervision of the infection control investigators in
each ward. The director of the team was in charge of
study design and data collection.
Before the survey, definitions of the investigated vari-
ables in the questionnaire were circulated to all involved
investigators and all investigators agreed on the inter-
pretation of the diagnostic criteria. The importance of
data completeness was highlighted among those investi-
gators who collected data.
Data was extracted from all relevant sources including
clinical records, temperature charts, laboratory reports and
radiographs. Additionally, investigators could request add-
itional information from nurses, doctors, or pharmacists.
Information was filled in via the Hospital Information
System. The questionnaire contained four sections, includ-
ing 1) demographics, 2) presence of HAI and organisms re-
sponsible for HAI (when appropriate), 3) exposure to
invasive devices (central/peripheral intravascular catheter,
Indwelling urinary catheter and mechanical ventilation)
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and 4) antibiotic prescription. Exposure to invasive devices
was defined as using the devices for at least 48 h at 8 a.m.
on the survey days.
Surveys were checked after completion by the team to
avoid missing data. A return visit was performed if pa-
tients or medical records were temporarily unavailable at
the onset of investigation. Infection reports were followed
up thereafter to investigate suspected microorganisms.
Data analysis
Continuous variables are presented as mean ± standard
deviation, and categorical variables are shown as percent-
ages. The prevalence of HAI (defined as the number of in-
fected patients divided by the total number of patients)
and the constituent ratio of a specific HAI (defined as a
specific type of HAI divided by the total number of HAI)
were assessed. The 95 % confidence intervals (CI) for each
parameter were also estimated.
For potential risk factors, variables with a P-value of
less than 0.05 in a univariate analysis were selected and
included in a multivariate logistic regression model.
Odds ratio (OR) and 95 % CI were evaluated to assess
associations between risk factors and HAI.
Statistical analyses were performed using SAS 9.13
(SAS Institute Inc., Cary, NC). All tests were two-tailed
and P-value less than 0.05 was considered as statistically
significant.
Results
During the three point-prevalence surveys, 1,233 pa-
tients in 2012, 1,220 patients in 2013 and 1,576 patients
in 2014, with a total number of 4,029 patients were in-
cluded. Of these, 50.2 % were male. Ages of patients
ranged from two days to 106 years. The mean age was
55.9 ± 19.2 years. Out of all participants, 1,457 were ad-
mitted to medical department, 1,199 were in surgical
department, 892 were in traditional Chinese medical de-
partment, 120 were in ICUs, 73 were in the pediatric de-
partment, 65 were in the gynecology/obstetrics
department, and 223 were in the ophthalmology/oto-
rhinolaryngology department.
Prevalence and infection sites
Overall, 147 of 4,029 patients were diagnosed as HAI.
Among the 147 infected patients with a total of 167 in-
fected sites, single infection occurred in 130 patients
(88.4 %), double infections in 15 patients (10.2 %), triple
and quadruple infections both in one patient (0.7 %).
The overall prevalence of HAI was 3.6 % (95 % CI,
3.1 %–4.2 %) (Table 1).
RTI was the most common type of HAI (64.7 %),
followed by UTI (12.6 %), BSI (5.4 %), SSI (4.8 %), DTI
(3.6 %) and SSTI (3.0 %). Other infections accounted for
6.0 % (Table 1).
Risk factors
Univariate analyses showed that HAI prevalence was sig-
nificantly higher in patients of male sex (5.0 %), older than
85 years (18.7 %) and hospitalized in ICUs (35.0 %). Add-
itionally, patients who were exposed to central/peripheral
intravascular catheter, indwelling urinary catheter or mech-
anical ventilation also had a significantly higher prevalence
of HAI (11.3 %, 12.1 %, 15.7 %, respectively) (Table 2).
Multivariate logistic regression analyses indicated male
sex, age of older than 85 years, hospitalization in ICUs,
indwelling urinary catheter and mechanical ventilation
were significantly associated with HAI. Crude OR and
adjusted OR with 95 % CI were listed in Table 2.
Isolated pathogens
Some of HAI episodes were diagnosed according to
physical symptoms and/or radiographs, and 66 % (97/
Table 1 Prevalence of HAI in a tertiary hospital in Beijing, China
2012 (n = 1,233) 2013 (n = 1,220) 2014 (n = 1,576) Total (n = 4,029)
N [% (95 % CI)] of patients with HAIa 34 [2.8 (1.8–3.7)] 63 [5.2 (3.9–6.4)] 50 [3.2 (2.3–4.0)] 147 [3.6 (3.1–4.2)]
N [% (95 % CI)]of HAIsb 42 [3.4 (2.4–4.4)] 69 [5.7 (4.4–7.0)] 56 [3.6 (2.6–4.5)] 167 [4.1 (3.5–4.8)]
N (constituent ratio) of sites with HAI
RTI 23 (54.8) 48 (69.6) 37 (66.1) 108 (64.7)
UTI 9 (21.4) 6 (8.7) 6 (10.7) 21 (12.6)
BSI 3 (7.1) 3 (4.3) 3 (5.4) 9 (5.4)
SSI 2 (4.8) 4 (5.8) 2 (3.6) 8 (4.8)
DTI 2 (4.8) 1 (1.4) 3 (5.4) 6 (3.6)
SSTI 0 (0.0) 3 (4.3) 2 (3.6) 5 (3.0)
Others 3 (7.1) 4 (5.8) 3 (5.4) 10 (6.0)
HAI healthcare-associated infection, RTI respiratory tract infection, UTI urinary tract infection, BSI bloodstream infection, SSI surgical site infection, DTI digestive tract
infection, SSTI skin and soft tissue infection
aNumber and proportion of infected patients in all patients
bNumber and proportion of infected sites in all patients
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147) of infected patients were found the presence of
pathogens in culture. In total, 143 pathogenic bacteria
types were isolated. Gram-negative bacteria were found to
be the most common isolated pathogens (67.1 %, 96/143),
followed by gram-positive bacteria, fungi, and others (such
as viruses) accounted for 20.3 % (29/143), 10.5 % (15/143)
and 2.1 % (3/143) of the pathogens, respectively.
Pseudomonas aeruginosa accounted for 18.9 % (27/143) of
isolates and was the most common cause of HAI,
followed by Acinetobacter baumannii (17.5 %, 25/143)
and Klebsiella pneumoniae (9.8 %, 14/143) (Table 3).
Antibiotic use
Antimicrobials were administered in 34.3 % (1,380/
4,029) of patients over the study period. Among patients
who received antimicrobials, 48.2 % (665/1,380) were
Table 2 Univariate and multivariate analyses comparing patients with and without HAI in relation to potential risk factors
Characteristics (N) With HAI (n = 147)
(N, %)
Without HAI (n = 3,882)
(N, %)
Crude OR (95 % CI),
P
Adjusted OR (95 % CI),
P a
Sex
Female (2,007) 45 (2.2) 1,962 (97.8) 1 1
Male (2,022) 102 (5.0) 1,920 (95.0) 2.32 (1.62–3.31),
P < 0.05
2.25 (1.53–3.32), P < 0.05
Age
≤ 17 years (133) 1 (0.8) 132 (99.2) 0.35 (0.05–2.58),
P = 0.31
0.55 (0.07–4.55), P = 0.58
18–34 years (506) 6 (1.2) 500 (98.8) 0.56 (0.24–1.32),
P = 0.19
0.82 (0.34–1.95), P = 0.65
35–64 years (1,949) 41 (2.1) 1,908 (97.9) 1 1
65–84 years (1,307) 99 (6.9) 1,342 (93.1) 2.79 (1.89–4.12),
P < 0.05
2.19 (1.44–3.32), P < 0.05
≥ 85 years (134) 25 (18.7) 109 (81.3) 10.67 (6.26–18.20),
P < 0.05
4.74 (2.54–8.83), P < 0.05
Wards
Medicine (1,457) 47 (3.2) 1,410 (96.8) 1 1
Surgery (1,199) 26 (2.2) 1,173 (97.8) 0.67 (0.41–1.08),
P = 0.10
0.29 (0.17–0.52), P < 0.05
Traditional Chinese Medicine (892) 32 (3.6) 860 (96.4) 1.12 (0.71–1.76),
P = 0.64
1.27 (0.79–2.05), P = 0.32
ICUb (120) 42 (35.0) 78 (65.0) 16.15 (10.05–25.96),
P < 0.05
2.42 (1.31–4.49), P < 0.05
Pediatrics (73) 0 (0.0) 73 (100.0) - -
Gynecology/Obstetrics (65) 0 (0.0) 65 (100.0) - -
Ophthalmology/Otorhinolaryngology (223) 0 (0.0) 223 (100.0) - -
Central/Peripheral arteriovenous catheter
No (3,532) 91 (2.6) 3,441 (97.4) 1 1
Yes (497) 56 (11.3) 441 (88.7) 4.80 (3.39–6.80),
P < 0.05
1.43 (0.87–2.36), P = 0.16
Indwelling urinary catheter
No (3,402) 71 (2.1) 3,331 (97.9) 1 1
Yes (627) 76 (12.1) 551 (87.9) 6.47 (4.63–9.06),
P < 0.05
4.21 (2.46–7.20), P < 0.05
Mechanical ventilation
No (3,710) 97 (2.6) 3,613 (97.4) 1 1
Yes (319) 50 (15.7) 269 (84.3) 6.92 (4.82–9.95),
P < 0.05
2.31 (1.30–4.09), P < 0.05
HAI healthcare-associated infection, ICU intensive care unit, OR odds ratio
aAdjusted for all included variables
bRefers to General ICU, Cardiovascular ICU, Emergency ICU, Kidney ICU and Respiratory ICU
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used for prophylaxis, 41.7 % (576/1,380) were used for
treatment, and 10.1 % (139/1,380) were used for both
purposes (Table 4).
Discussion
HAI is recognized as a public health threat, as well as a
safety issue for hospitalized patients nationally and inter-
nationally. This was the first attempt to review the epi-
demiology of HAI in a tertiary level hospital in Beijing,
with the same standardized methodology. Our study
demonstrated that the overall prevalence of patients with
HAI was 3.6 %. Our results were relatively stable in
three annual surveys, which provides basic information
to further evaluate the infection control program in our
hospital. Although variety in methodologies and study
population between different studies and comparable in-
fection rates require adjustment for intrinsic and extrin-
sic risk factors, the HAI prevalence in our hospital was
similar to studies conducted in other areas of China, in
which the MOH’s definition was used [10–12]. Our re-
sults were also similar to that of conducted in the USA
[16], but lower than other studies carried out in Italy,
Greek, Malaysia, England, Wales, Northern Ireland and
the Republic of Ireland (from 6.1 % to 13.9 %), in which
the CDC’s definition was used [17–20]. Differences be-
tween the prevalence data reported by other countries
and our survey may be explained by the differing lengths
of hospital stay, definitions of HAIs, sizes of hospitals,
and methods for measuring HAI.
Consistent with previous studies with similar design in
China [10–12], RTI was found to be the most common
HAI. In those studies conducted in China, including
ours, the HAI definition established by MOH was used.
The MOH’s definition, modified based on definition
from CDC [15], is similar to the CDC’s definition but
with some alterations. In the MOH’s definition, RTI
Table 3 Distribution of HAI pathogens in a tertiary hospital in Beijing, China, 2012–2014
Pathogens N of pathogens, by infection sites
RTI UTI BSI SSI DTI SSTI Others Total
Gram-negative bacteria 72 10 4 2 3 1 4 96
Pseudomonas aeruginosa 25 2 0 0 0 0 0 27
Acinetobacter baumannii 22 0 0 1 1 0 1 25
Klebsiella pneunoniae 11 1 1 0 0 0 1 14
Escherichia coli 1 5 2 1 0 0 1 10
Stenotrophomonas maltophilia 6 0 0 0 1 0 0 7
Others 7 2 1 0 1 1 1 13
Gram-positive bacteria 15 2 3 2 2 3 2 29
Staphylococcus aureus 4 0 0 2 0 2 1 9
CNS 3 1 0 0 1 0 1 6
Enterococcus spp. 2 1 1 0 0 0 0 4
Streptococcus spp. 3 0 0 0 0 0 0 3
Others 3 0 2 0 1 1 0 7
Fungus 11 3 0 0 0 1 0 15
Candida albicans 7 1 0 0 0 0 0 8
Others 4 2 0 0 0 1 0 7
Others 3 0 0 0 0 0 0 3
Total 101 15 7 4 5 5 5 143
HAI healthcare-associated infection, CNS Coagulase-negative Staphylococcus, RTI respiratory tract infection, UTI urinary tract infection, BSI bloodstream infection, SSI
surgical site infection, DTI digestive tract infection, SSTI skin and soft tissue infection
Table 4 Antibiotic use in a tertiary hospital in Beijing, China
2012 (n = 1,233) 2013 (n = 1,220) 2014 (n = 1,576) Total (n = 4,029)
Antibiotics use (N, %) 445 (36.1) 414 (33.9) 521 (33.1) 1,380 (34.3)
Purpose of antibiotic use, (N, %)
Prophylactic 226 (50.8) 182 (44.0) 257 (49.3) 665 (48.2)
Treatment 179 (40.2) 199 (48.1) 198 (38.0) 576 (41.7)
Treatment & Prophylactic 40 (9.0) 33 (8.0) 66 (12.7) 139 (10.1)
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contains cases of “pneumonia”, “lower respiratory tract
infection other than pneumonia”, as well as “upper re-
spiratory infection” if a patient has a fever with higher
than 38 °C. The broader RTI definition used by the
MOH is likely to result in a higher prevalence of RTI in
western countries, compared to the definition adopted
by the CDC. The data of our study was comparable to
other countries’ results except for RTI.
Similar with previous investigations [21–23], our study
showed that patients older than 85 years of age, hospital-
ized in ICUs, indwelling urinary catheter and mechanical
ventilation were significantly associated with an in-
creased risk of HAI. Therefore, strategies of infection
control in our hospital should be focused on these fac-
tors in the future. Male sex as a risk factor in our ana-
lysis was an interesting finding, which was also found to
be significant in Balkhy’s study [23]. However, this find-
ing was inconsistent with some other studies [21, 22].
This result needs to be confirmed by other researchers.
Length of stay, a significant potential risk factor for HAI,
was not collected in our study because we thought in a
cross-sectional study, it would be hard to explain whether
a longer hospital stay would generate an infection, or an
infection would result in a longer hospital stay. It’s note-
worthy that, some other important risk factors associated
with HAI were not considered in the questionnaire, such
as underlying disease, duration of invasive devices, con-
scious state, glucocorticoid use, and immunoglobulin use,
and these need further exploration.
Microbiological documentation was available for 66 % of
infected patients. This proportion is higher than previous
results [10, 11, 21]. Overestimating the prevalence of HAI
might be possible, as some of HAI episodes were diagnosed
by physical symptoms and/or radiographs. Gram-negative
bacteria seemed more responsible than Gram-positive bac-
teria for isolated HAI. It might be due to the abuse of anti-
microbials both before and during the hospital admission.
According to China Food and Drug Administration’s re-
port, about 30 % of people use antimicrobials at home to
treat a common cold or diarrhea [24]. Use of antimicrobials
in hospital is also high, with the proportion of 54.8 % in
2001 and 46.6 % in 2010 [25]. The proportion of meticillin-
resistant Staphylococcus aureus (MRSA) among all
Staphylococcus aureus was 44.4 %, but there were only 9
isolates of Staphylococcus aureus in total and it is therefore
hard to draw a clear conclusion. In contrast to MRSA, the
major isolated pathogen within infected patients in Greek,
Morocco, and Saudi Arabia was Pseudomonas aeruginosa
[18, 21, 26], In addition, Acinetobacter baumannii, Escheri-
chia coli and Klebsiella pneunoniae were also common in
China [10–12].
In a point-prevalence survey of antibacterial use in 20
European hospitals, 30.1 % of inpatients were receiving
antibacterial on the survey day [27]. Another point
prevalence survey revealed that 34.6 % were receiving at
least one antimicrobial agent [28]. Consistent with above
studies, our study found 34.3 % of patients were receiv-
ing antimicrobials at the time of survey. Previously,
abuse of antimicrobial was a major concern in China
[24, 25]. Currently lower proportion of antimicrobial use
may be due to the new policy about antibiotic manage-
ment, initiated by the MOH in May 2011 aiming to
standardize antibiotic consumption and to reduce anti-
biotic overuse [29]. The stringent policies includes
restricting clinical indications on antibiotic use and de-
fining daily dose (DDD) under 40 per 100 patients per
day, limiting antimicrobial varieties in hospitals, and cut-
ting off economic connections between pharmaceutical
companies and doctors.
However, the proportion of patients who receive anti-
biotic prophylaxis is still very high since antibiotic
prophylaxis was associated with a decreased risk of SSI,
which may result in higher mortality and morbidity.
Many surgeons tend to extend the duration of prophy-
lactic antibiotic use, despite the clinical guidelines rec-
ommend discontinuation of prophylactic antibiotics
within 24 h after surgery. SSI rates after surgery have
been observed to range from 30 % to 60 % without
prophylactic antibiotics, but prophylactic antibiotic use
could dramatically reduce the risk of SSI [30–32]. So it
might be that a higher antibiotic prophylaxis use rate
lead to a lower SSI rate in our hospital.
Several limitations of our study should be noted.
Firstly, patients with longer duration of hospital stay
were more likely to have their infection details recorded,
compared to patients with shorter stay. Thus, it is pos-
sible that the persistent infections were overestimated
while the temporary infections were underestimated.
Secondly, cross-sectional study does not allow to con-
clude causality between different factors and HAI. Last,
it is impossible to calculate the HAI incidence rate with
a cross-sectional design.
Conclusions
Despite the limitations mentioned above, our study
yielded valuable data on the epidemiology of HAI, in-
cluding point-prevalence, potential risk factors, isolated
pathogens and antibiotic use among inpatients in a ter-
tiary hospital in Beijing, China. The overall HAI preva-
lence in our hospital is similar to previous studies that
were conducted in other areas of China, and the respira-
tory tract infection should be the priority in HAI reduc-
tion control within China. We should focus HAI
reduction efforts on patients with advanced age,
hospitalization in the ICU and indwelling devices.
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